Navigation Links
Bauer Calls Taxpayer-Funded Embryonic Stem Cell Research 'A Tragedy'
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- Former Presidential candidate Gary Bauer on Monday called Barack Obama's decision to waste federal tax dollars on failed embryonic stem cell research "evidence that ideology is the goal here, not saving lives. We are witnessing the beginnings of a tragedy, as lives will be lost and not saved as a result of this change."

The president of American Values made the following statement: "It's tragic that Barack Obama is willing to take tax money from struggling Americans and give it to scientists working on repeatedly failed embryonic stem cell projects...especially as adult stem cell research is yielding real, life-saving results. Most people do not understand that there is no restriction against fetal stem cell research, just a restriction against spending tax dollars to destroy human embryos for a body of work that has resulted in cancers and abnormal cells time and time again. Adult stem cell research, on the other hand, has provided real hope to many patients. In 2008, the National Institutes of Health spent nearly one billion dollars on stem cell research, most of it going to adult stem cell research because of the real hope it offered.

"This policy shift is part of an anti-life agenda that now will allow human embryos to be destroyed to create cell lines. My concern is that the long-term result of this work will lead to a lifting of the ban against human cloning, a development that would allow testing in laboratories on human embryos, human life. But today, Obama's decision to allow federal tax dollars to be used to destroy human embryos is tragic on many levels. He raises false hope for those who are ill; he strains the American taxpayer at a time of economic crisis, and he ignores the humanity of the lives ended in cold laboratories to satisfy a liberal ideology."


'/>"/>
SOURCE American Values
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. CFSO Calls for Roundtable to Develop National Strategy for Advancing Forensic Sciences in the United States
2. China Bio-Immunity Corporation Initiates Voluntary Recalls of Rabies Vaccines
3. Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees
4. Kaiser Permanente CEO Calls for Connected Health Care
5. International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive
6. ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets
7. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Frost & Sullivans Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
10. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
11. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):